Article
Knick-knack PADIMAC
15 Nov 2018
Abstract excerpt
In this issue of Blood , Chapman et al 1 have derived a 7-gene expression signature that predicts whether a newly diagnosed myeloma patient will respond to treatment with bortezomib when autologous stem cell transplant (ASCT) is not considered as part of the upfront therapy.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.